Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

Serkan Guven, Deniz Özmen, Yunus Çatma, Tuba Güllü Koca, Onur Kırkızlar, Ömer Şeker, Sercan Ünal, Seçil Salim, Betül Kübra Tüzün, Aslı Yüksel Öztürkmen, Nergiz Erkut, Esra Kiriktir, Nesibe Taşer Kanat, Püsem Patır, Abdülkadir Karışmaz, Seval Akpınar, Emel Gürkan, Nurcan Özçelik Kürkçü, Öznur Aydın, Gülsüm Çağlıyan, Ayfer Gedük, Süleyman Arslan, Zehra Narlı Özdemir, Rafiye Çiftçiler, Ayşe Uysal, Merve Aydoğan, Yıldız İpek, Merve Ecem Erdoğan Yön, Zeynep Tuğba Karabulut, Emel Bostan, Sinan Mersin, Tarık Onur Tiryaki, Vildan Gürsoy, İrfan Yavaşoğlu, Ali Doğan, Güchan Alanoğlu, Mehmet Baysal, Eren Arslan Davulcu, Ayşe Kaya, İbrahim Ethem Pınar, Abdülkerim Yıldız, Gülşah Akyol, İnci Alacacıoğlu, Mutlu Arat, Mesut Ayer, Meltem Aylı, İlhami Berber, Ahmet Muzaffer Demir, İbrahim Haznedaroğlu, Fehmi Hindilerden, Erdal Kurtoğlu, Meliha Nalçacı, Fahir Özkalemkaş, Vildan Özkocaman, Güray Saydam, Mehmet Sönmez, Selami Koçak Toprak, Tülin Tuğlular, Burhan Turgut, Mehmet Turgut, Ahmet Emre Eskazan

Blood (2024) 144 (Supplement 1): 6585.

https://doi.org/10.1182/blood-2024-193433

Published: 2024

Journal Articles

A Single Center Real-World Data Comparing Salvage Autologous Hematopoietic Stem-Cell Transplantation, Selinexor Combo and Elranatamab Alone Among Triple Class Refractory Myeloma Patients: Better Efficacy with Elranatamab

Guldane Cengiz Seval, Gul Yavuz, Gulcin Miyase Sonmez, Goren Arik, Fatma Selin Yildirim, Selami Kocak Toprak, Pervin Topçuoğlu, Meral Beksac

Blood (2023) 142 (Supplement 1): 6668.

https://doi.org/10.1182/blood-2023-173644

Published: 2023

Journal Articles

Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematology-Acute Myeloid Leukemia Working Group

Blood (2023) 142 (Supplement 1): 5838.

https://doi.org/10.1182/blood-2023-187351

Published: 2023

Journal Articles

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Blood (2023) 142 (Supplement 1): 4734.

https://doi.org/10.1182/blood-2023-179416

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Derya Koyun, Uğur Şahin, Güldane Cengiz Seval, Deniz Gören Şahin, Ayla Gökmen, Sinem Civriz Bozdağ, Selami Kocak Toprak, Pervin Topçuoğlu, Meltem Kurt Yüksel, Önder Arslan, Taner Demirer, Günhan Gürman, Osman İlhan, Meral Beksac, Muhit Özcan, Mutlu Arat

Blood (2023) 142 (Supplement 1): 3617.

https://doi.org/10.1182/blood-2023-182741

Published: 2023

Journal Articles

Prospective Real-World Outcomes of Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 5834.

https://doi.org/10.1182/blood-2023-182800

Published: 2023

Journal Articles

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Derya Koyun, Guldane Cengiz, Sinem Civriz Bozdag, Selami Kocak Toprak, Pervin Topçuoğlu, Muhit Özcan, Onder Arslan, Taner Demirer, Osman İlhan, Gunhan Gurman, Meral Beksac, Meltem Kurt Yuksel

Blood (2022) 140 (Supplement 1): 12673–12674.

https://doi.org/10.1182/blood-2022-155998

Published: 2022

Journal Articles

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

Hulya Yilmaz, Guldane Cengiz, Bulent Karakaya, Gul Yavuz, Merve Aydogan, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topçuoğlu, Onder Arslan, Muhit Ozcan, Osman Ilhan, Meral Beksac

Blood (2022) 140 (Supplement 1): 4369–4370.

https://doi.org/10.1182/blood-2022-170132

Published: 2022

Journal Articles

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Osman Ilhan, Guldane Cengiz Seval, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Onder Arslan, Muhit Özcan, Taner Demirer, Gunhan Gurman, Meral Beksac

Blood (2021) 138 (Supplement 1): 4906.

https://doi.org/10.1182/blood-2021-153905

Published: 2021

Journal Articles

Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Guldane Cengiz, Bulent Karakaya, Hulya Yilmaz, Derya Koyun, Ekin Kircali, Sevgi Basboga, Selami Kocak Toprak, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Pervin Topcuoglu, Gunhan Gurman, Trinayan Kashyap, James Niblock, Meral Beksac

Blood (2021) 138 (Supplement 1): 4904.

https://doi.org/10.1182/blood-2021-148835

Published: 2021

Journal Articles

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Guldane Cengiz Seval, Atilla Uslu, MD, Ekin Kircali, Sinem Civriz Bozdag, MD, Klara Dalva, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Isinsu Kuzu, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2019) 134 (Supplement_1): 2019.

https://doi.org/10.1182/blood-2019-128750

Published: 2019

Journal Articles

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Guldane Cengiz Seval, Nergis Ozturk, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Selami Kocak Toprak, MD

Blood (2019) 134 (Supplement_1): 4504.

https://doi.org/10.1182/blood-2019-127651

Published: 2019

Journal Articles

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Ekin Kircali, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Pervin Topcuoglu, MD

Blood (2019) 134 (Supplement_1): 4156.

https://doi.org/10.1182/blood-2019-127622

Published: 2019

Journal Articles

Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

Blood (2019) 134 (Supplement_1): 4805.

https://doi.org/10.1182/blood-2019-128743

Published: 2019

Journal Articles

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Erden Atilla, MD, Pervin Topcuoglu, MD, Erman Akkus, MD, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Taner Demirer, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Hamdi Akan, MD, Onder Arslan, MD, Gunhan Gurman, MD, Selami Kocak Toprak, MD

Blood (2018) 132 (Supplement 1): 3472.

https://doi.org/10.1182/blood-2018-99-118314

Published: 2018

Journal Articles

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Guldane Cengiz Seval, Bahar Ulas, Onur Tascı, Fulya Ozel, MD, Buğu Bulat, Isinsu Kuzu, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Muhit Özcan, Meral Beksac, MD, Osman Ilhan, MD, Gunhan Gurman, Onder Arslan

Blood (2018) 132 (Supplement 1): 5331.

https://doi.org/10.1182/blood-2018-99-120370

Published: 2018

Journal Articles

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Gunhan Gurman, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Hamdi Akan, MD

Blood (2018) 132 (Supplement 1): 4673.

https://doi.org/10.1182/blood-2018-99-120202

Published: 2018

Journal Articles

Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Erden Atilla, MD, Merih Yalciner, MD, Ozlem Kilic, RN, Nurhayat Muftuoglu, RN, Pinar Ataca Atilla, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Muhit Özcan, Gunhan Gurman, MD, Osman Ilhan, MD

Blood (2018) 132 (Supplement 1): 5902.

https://doi.org/10.1182/blood-2018-99-118275

Published: 2018

Journal Articles

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Pervin Topcuoglu, MD, Guldane Cengiz Seval, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Klara Dalva, MD, Onder Arslan, MD, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2018) 132 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2018-99-120166

Published: 2018

Journal Articles

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Osman Ilhan, MD, Guldane Cengiz Seval, Selami Kocak Toprak, MD, Pervin Topcuoglu, MD, Fulya Ozel, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Hamdi Akan, Meral Beksac, MD, Gunhan Gurman

Blood (2017) 130 (Supplement 1): 5480.

https://doi.org/10.1182/blood.V130.Suppl_1.5480.5480

Published: 2017

NARROW

Real-Life Outcomes of Bosutinib in Patients with Chronic Myeloid Leukemia: A Multicenter Nationwide Study from Turkey

A Single Center Real-World Data Comparing Salvage Autologous Hematopoietic Stem-Cell Transplantation, Selinexor Combo and Elranatamab Alone Among Triple Class Refractory Myeloma Patients: Better Efficacy with Elranatamab

Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematology-Acute Myeloid Leukemia Working Group

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Prospective Real-World Outcomes of Acute Myeloid Leukemia

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Single Center Real World Data That Compares Autologous Stem Cell Transplant in the Era of Anti-CD38 Monoclonal Antibody Based Treatments for AL Amyloidosis

The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Comparison of Salvage Autologous Hematopoietic Cell Transplantation with Outcomes Following Selinexor Combinations Among Double/Triple Refractory Myeloma Patients

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Evaluation of Elderly Patients with Hematological Malignancies By Two Different Geriatric Risk Scoring Systems: G8 and Flemish Version of the Triage Risk Screening Tool (fTRST)

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only